Zobrazeno 1 - 10
of 107
pro vyhledávání: '"G S, Kolesnikova"'
Autor:
B M Shifman, N M Platonova, N V Molashenko, E A Troshina, I I Sitkin, D G Belcevich, L D Kovalevich, N Yu Romanova, G S Kolesnikova
Publikováno v:
Терапевтический архив, Vol 91, Iss 10, Pp 91-99 (2019)
Primary hyperaldosteronism (PA) - is the clinical syndrome, results from autonomous of the major regulators of secretion, aldosterone overproduction by a tumorous or hyperplastic tissue in adrenal cortex. Being the most frequent cause of secondary hy
Externí odkaz:
https://doaj.org/article/e6c88c1df6ed48148f4407f645244772
Autor:
A. G. Saribekian, D. A. Petrenko, D. A. Trukhina, A. G. Kuzmin, L. K. Dzeranova, L. V. Nikankina, G. S. Kolesnikova
Publikováno v:
Clinical and experimental thyroidology. 17:17-20
Thyroid stimulating hormone (TSH) is one of the key indicators in the diagnosis of the thyroid gland functional disorders. Minor changes in TSH concentration make it possible to suspect thyroid dysfunction even before clinical manifestations, which i
Autor:
I I Dedov, A V Belyaeva, L Ya Rozhinskaya, N G Mokrysheva, S S Mirnaya, G S Kolesnikova, A V Il'in, N I Sazonova, T O Chernova, A M Artemova, A. V. Belyaeva, L. Y. Rozhinskaya, N. G. Mokrysheva, S. S. Mirnaya, G. S. Kolesnikova, A. V. Ilyin, N. I. Sazonova, T. O. Chernova, A. M. Artemova
Publikováno v:
Остеопороз и остеопатии, Vol 13, Iss 1, Pp 6-12 (2010)
Primary hyperparathyroidism (PHPT) is a common disorder often associated with reduced bone mineral density (BMD) and osteoporosis. The main goal in treating patients who refuse surgery is the correction of bone complications. The aim of this study is
Externí odkaz:
https://doaj.org/article/e176aeeb00be4c4b96037a142b6600d3
Autor:
A. M. Lapshina, E. Yu. Nadezhdina, O. V. Ivashchenko, O. Yu. Rebrova, A. Yu. Grigoriev, G S Kolesnikova, Vilen N Azizyan
Publikováno v:
Russian journal of neurosurgery. 22:39-48
The study objective is to compare pre- and intraoperative characteristics, and the results of neurosurgical treatment in patients with Cushing’s disease, non-visualized adenoma and microadenoma of the pituitary gland.Materials and methods. The resu
Autor:
D G Belcevich, I I Sitkin, Nadezhda M. Platonova, N. Yu. Romanova, Molashenko Nv, L D Kovalevich, G S Kolesnikova, E A Troshina, Boris M. Shifman
Publikováno v:
Терапевтический архив, Vol 91, Iss 10, Pp 91-99 (2019)
Primary hyperaldosteronism (PA) - is the clinical syndrome, results from autonomous of the major regulators of secretion, aldosterone overproduction by a tumorous or hyperplastic tissue in adrenal cortex. Being the most frequent cause of secondary hy
Autor:
Zh E Belaya, L Ya Rozhinskaya, G A Mel'nichenko, A V Il'in, N V Dragunova, G S Kolesnikova, S A Butrova, E A Troshina
Publikováno v:
Остеопороз и остеопатии, Vol 14, Iss 2, Pp 7-10 (2011)
Цель: оценить возможности маркёра костеобразования - остеокальцина (ОК) для диагностики эндогенного гиперкортицизма. Материалы и метод
Externí odkaz:
https://doaj.org/article/762644ed8a6e4fdebdd0e2c10e694381
Autor:
E. N. Giniyatullina, L. Ya. Rozhinskaya, L. K. Dzeranova, N. G. Mokrysheva, N. I. Sazonova, G. S. Kolesnikova, A. D. Dobracheva, N. P. Goncharov
Publikováno v:
Остеопороз и остеопатии, Vol 12, Iss 1, Pp 14-18 (2008)
Hypogonadism is the most popular cause of BMD decreasing not only in women, but also in men. There are several studies showed a correlation between duration of hypogonadism and BMD reducing degree. Despite wide light exposure of osteoporosis problem
Externí odkaz:
https://doaj.org/article/8535261998e14905bafb3f8c272588b5
Publikováno v:
Остеопороз и остеопатии, Vol 11, Iss 2, Pp 6-9 (2008)
Central diabetes insipidus is a rare pituitary disease due to impairment of synthesis or/and secretion of vasopressin (AVP), characterized by polyuria, polydipsia, low urine osmolality and hyperosmolality of plasma. Main therapy for CDI is substituti
Externí odkaz:
https://doaj.org/article/ef441a66987041d1a1e85ce83f460e06
Autor:
Zh E BELAYa, L Ya ROZhINSKAYa, G S KOLESNIKOVA, A V IL'IN, N I SAZONOVA, T O ChERNOVA, T M ALEKSEEVA, O K DOROFEEVA, E I GOL'DMAN, S I PIMENOVA, G A MEL'NIChENKO
Publikováno v:
Остеопороз и остеопатии, Vol 10, Iss 1, Pp 12-19 (2007)
The aim was to estimate the effects of treatment with alendronate (Fosomax 35 mg) in postmenopausal women with osteoporosis and subclinical hyperthyroidism. Thirty postmenopausal women (64 (60-69) years old) with osteoporosis (T-score ≤ -2,5) and s
Externí odkaz:
https://doaj.org/article/872ef5e6dbfe4162a834426d075a74f1
Autor:
A Yu Grigor'ev, O V Ivashchenko, G A Mel'nichenko, E I Marova, A V Vorontsov, V P Vladimirova, G S Kolesnikova
Publikováno v:
Эндокринная хирургия, Vol 1, Iss 1, Pp 24-27 (2007)
Болезнь Иценко-Кушинга является редким и тяжелым нейроэндокринным заболеванием, причиной которого, в большинстве случаев, является аде
Externí odkaz:
https://doaj.org/article/2f48aa6b8bba4e69a83af3ca429000d2